ALB and liver cancer: However, several limitations existed in the current study: (1) other liver function indicators, such as indirect bilirubin and albumin would be determined, which are influence factors affecting the treatment of liver cancer; (2) Further randomized controlled trial with larger sample size is needed to validated our result; (3) The power of sample size should be calculated to avoid conclusion bias.